Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
Biosimilars Act Will Give Americans Access to Cutting Edge Medications at Lower Prices Washington, D.C.—July … development costs that are associated with these cutting-edge treatments, they are among the most expensive drugs